Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-020537
Filing Date
2020-05-01
Accepted
2020-05-01 16:54:56
Documents
5
Effectiveness Date
2020-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A cbio-defa14a_20200611.htm DEFA14A 42912
2 GRAPHIC gzgsx53ogwfo000003.jpg GRAPHIC 46977
3 GRAPHIC gzgsx53ogwfo000002.jpg GRAPHIC 90795
4 GRAPHIC gzgsx53ogwfo000004.jpg GRAPHIC 44046
5 GRAPHIC gzgsx53ogwfo000001.jpg GRAPHIC 76092
  Complete submission text file 0001564590-20-020537.txt   399681
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51173 | Film No.: 20841590
SIC: 2834 Pharmaceutical Preparations